Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?
Authors
Keywords
-
Journal
SEMINARS IN ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-02-07
DOI
10.1053/j.seminoncol.2023.01.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of tumor‑associated neutrophils in lung cancer (Review)
- (2022) Jinhua Zhou et al. Oncology Letters
- Dynamic roles of inflammasomes in inflammatory tumor microenvironment
- (2021) Jeong-Hoon Jang et al. npj Precision Oncology
- The Role of Tumor Inflammatory Microenvironment in Lung Cancer
- (2021) Zhaofeng Tan et al. Frontiers in Pharmacology
- Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis
- (2020) Jiawen Zhao et al. Cancer Cell International
- Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)
- (2020) Ye Li et al. Frontiers in Oncology
- Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab
- (2020) Giuseppe Luigi Banna et al. Translational Lung Cancer Research
- Validation of the 8th edition of the TNM staging system in 3,950 patients with surgically resected non-small cell lung cancer
- (2019) Jae Kwang Yun et al. Journal of Thoracic Disease
- Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection
- (2019) Dai Sonoda et al. Cancer Management and Research
- Prognostic significance of neutrophil–lymphocyte ratio (NLR) in patients with ovarian cancer
- (2019) Xinming Yin et al. MEDICINE
- Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
- (2019) Qinge Shan et al. PeerJ
- Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
- (2019) Rachel Howard et al. Scientific Reports
- Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
- (2018) E Dell’Aquila et al. ANNALS OF ONCOLOGY
- Publisher Correction: Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
- (2018) Xinyi Guo et al. NATURE MEDICINE
- PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
- (2018) Roman M. Chabanon et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer
- (2017) Yu-Suo Tong et al. Journal of Translational Medicine
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
- (2017) Stefan Diem et al. LUNG CANCER
- Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis
- (2017) Qiang Liu et al. Molecular Cancer
- Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer
- (2017) Yuan Gao et al. Oncotarget
- International Adaptations of NCCN Clinical Practice Guidelines in Oncology
- (2017) Robert W. Carlson et al. Journal of the National Comprehensive Cancer Network
- Factores pronóstico en el carcinoma bronquial no microcítico menor de 3 centímetros (análisis actuarial, incidencia acumulativa y grupos de riesgo)
- (2015) Juan C. Peñalver Cuesta et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database
- (2015) Christopher D. Corso et al. Journal of Thoracic Oncology
- Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy
- (2015) Lei Liang et al. Oncotarget
- Factores pronóstico en el carcinoma bronquial no microcítico menor de 3 centímetros (análisis actuarial, incidencia acumulativa y grupos de riesgo)
- (2015) Juan C. Peñalver Cuesta et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the Staging Project Database of the International Association for the Study of Lung Cancer
- (2013) David Ball et al. Journal of Thoracic Oncology
- Local recurrence following lung cancer surgery: Incidence, risk factors, and outcomes
- (2013) David Fedor et al. SURGICAL ONCOLOGY-OXFORD
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer
- (2012) Chao-Yu Liu et al. EUROPEAN RESPIRATORY JOURNAL
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables
- (2011) Thierry Berghmans et al. Therapeutic Advances in Medical Oncology
- Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation
- (2010) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started